Livongo Health
A new study conducted by the digital chronic disease management company highlighted engagement behaviors associated with stronger outcomes over 12 months.
Large health tech customers are more cautious and overwhelmed than ever, which means that many younger digital health startups will face an uphill battle selling their products in the months to come.
"Remote monitoring is here to stay," CEO Zane Burke said during yesterday's earnings call.
Livongo Health, Hinge Health, Hello Heart, Torchlight and Whil each underwent "rigorous clinical, data security and business evaluation" for inclusion in the program.
Although it's still operating in the red, the digital chronic disease management company logged 149% revenue growth in 2019.
According to a Wall Street Journal report, the digital chronic disease management company is eyeing a $1B-plus valuation.
Also: 23andMe's global privacy officer departs for global law firm; Oscar Health hires IBM Watson Health's corporate communications head.
Virta Health claims to reverse Type 2 diabetes by combining a digital intervention with a ketogenic diet.
This weekend saw the kickoff of the American Diabetes Association’s 78th annual conference, and with it a slew of new data from diabetes management players.
Livongo Health, the diabetes management startup launched last year by former Allscripts CEO Glen Tullman, will roll out its platform to a large group of New Yorkers via the Mount Sinai health system.